Key statistics
On Thursday, Biontech SE (22UA:STU) closed at 95.85, 37.32% above the 52 week low of 69.80 set on Aug 05, 2024.
52-week range
Open | 96.40 |
---|---|
High | 97.05 |
Low | 95.85 |
Bid | 95.20 |
Offer | 96.80 |
Previous close | 96.40 |
Average volume | 2.61k |
---|---|
Shares outstanding | 240.39m |
Free float | 214.95m |
P/E (TTM) | -- |
Market cap | 26.69bn USD |
EPS (TTM) | -3.69 USD |
Data delayed at least 15 minutes, as of Jul 17 2025.
More ▼
- BioNTech Announces Ryan Richardson to Step Down from the Management Board
- BioNTech gibt den Rücktritt von Ryan Richardson aus dem Vorstand bekannt
- EQS-News: GENUI sells labor team to Galenica
- EQS-News: Mallia Innovations: Mallia Appoints Jens Holstein, Dr. Alexandra Ogilvie, and Dr. Ulrich Dauer to its Advisory Board
- EQS-News: MIG Capital Announces €50 Million in Series A Funding for Look Up
- BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer
- BioNTech kündigt strategische Transaktion zur Übernahme von CureVac im Rahmen eines öffentlichen Umtauschangebots an
- EQS-News: Mallia sets strategic course for future and completes €5.5 million financing
- BioNTech und Bristol Myers Squibb geben globale strategische Partnerschaft zur gemeinsamen Entwicklung und Kommerzialisierung des bispezifischen Antikörperkandidaten BNT327 in einer Vielzahl solider Tumorarten bekannt
- BioNTech and Bristol Myers Squibb Announce Global Strategic Partnership to Co-Develop and Co-Commercialize Next-generation Bispecific Antibody Candidate BNT327 Broadly for Multiple Solid Tumor Types
More ▼